The American Journal of Managed Care > March 2020
The American Journal of Managed Care - March 2020
March 12, 2020 – Laurel A. Copeland, PhD; Erin P. Finley, PhD; Dawne Vogt, PhD; Daniel F. Perkins, PhD; and Yael I. Nillni, PhD
A survey of veterans leaving the military in 2016 found that women may be underserved by the Veterans Health Administration and may need housing assistance.
March 11, 2020
Correction to the Original Research article “Impact of Complex Care Management on Spending and Utilization for High-Need, High-Cost Medicaid Patients” published in the February 2020 issue of The American Journal of Managed Care®.
March 13, 2020
To mark the 25th anniversary of the journal, each issue in 2020 will include an interview with a healthcare thought leader. For the March issue, which marks the 10th anniversary of the Affordable Care Act being signed into law, we turned to Representative Frank Pallone Jr, D-New Jersey, who played a key role in the law’s writing and passage.
March 10, 2020 – Klaus W. Lemke, PhD; Kiemanh Pham, MD, MPH; Debra M. Ravert, MD; and Jonathan P. Weiner, DrPH
An updated emergency visit classification tool enables managers to make valid inferences about levels of appropriateness of emergency department utilization and healthcare needs within a population.
December 19, 2019 – Glenn Melnick, PhD; and Katya Fonkych, PhD
We find that under current regulatory and market conditions, demand for hospital-based emergency services is highly inelastic with respect to price, giving hospitals substantial pricing power over out-of-network emergency services.
March 15, 2020 – Patrick Liu, AB; Sanket S. Dhruva, MD, MHS; Nilay D. Shah, PhD; and Joseph S. Ross, MD, MHS
Out-of-pocket costs required by Medicare prescription drug plans for drugs available through Walmart’s generic drug discount program have decreased from 2009 to 2017.
TRENDS FROM THE FIELD
March 16, 2020 – Alex J. Hollingsworth, PhD; Ashley M. Kranz, PhD; and Deborah Freund, PhD
Care management was effective at reducing infant mortality among the most vulnerable infants enrolled in an Ohio Medicaid managed care organization.
March 05, 2020 – Richard L. Sheer, BA; Richard L. Barron, MS; Lavanya Sudharshan, MS; and Margaret K. Pasquale, PhD
This study provides proof of concept that imminent risk of fracture can be assessed by evaluating recent fracture, age, sex, race, medically significant falls, and psychoactive medications.
Medication Nonadherence, Mental Health, Opioid Use, and Inpatient and Emergency Department Use in Super-Utilizers
March 05, 2020 – Satya Surbhi, PhD, MS, BPharm; Ilana Graetz, PhD; Jim Y. Wan, PhD, MPhil; Justin Gatwood, PhD, MPH; and James E. Bailey, MD, MPH
Nonadherence to essential chronic medications and mental health diagnosis were associated with higher hospitalizations and emergency department use among Medicare super-utilizers.
March 06, 2020 – Brant Morefield, PhD; Lisa Tomai, MS; Vladislav Slanchev, PhD; and Andrea Klemes, DO
We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.
March 06, 2020 – Jordan Wirtz, MS-HSM; Sarah H. Ailey, PhD, PHNA-BC, CDDN; Samuel Hohmann, PhD, MS-HSM; and Tricia Johnson, PhD
Patients with intellectual disabilities who were cared for in hospitals without programs tailored to intellectual disabilities had 6% higher costs, and those with extreme admission severity had 42% higher costs.
March 10, 2020 – Anna Hung, PharmD, PhD; Bhavna Jois, BS; Amy Lugo, PharmD; and Julia F. Slejko, PhD
This study assesses the cost-effectiveness of adding a sodium-glucose cotransporter 2 inhibitor versus switching to a glucagon-like peptide-1 receptor agonist in patients with diabetes on metformin and a dipeptidyl peptidase-4 inhibitor.